Low-dose doxepin formulations and methods of making and using the same
US10548871B2 · kind B2 · utility
0Cited by
0References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 5, 2018 |
| Grant date | Feb 4, 2020 |
| Priority date | — |
| Expiry date | Mar 5, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/20
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention disclosed herein generally relates to low-dose oral doxepin pharmaceutical formulations and the use of these formulations to promote sleep.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.